SIC
GH icon

SJS Investment Consulting’s Guardant Health GH Stock Holding History

SJS Investment Consulting’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.7K Buy
98
+8
+9% +$870 ﹤0.01% 912
2026
Q1 		$8.31K Buy
90
+2
+2% +$201 ﹤0.01% 892
2025
Q4 		$8.99K Buy
88
+83
+1,660% +$7.42K ﹤0.01% 812
2025
Q3 		$313 Hold
5
– – ﹤0.01% 1359
2025
Q2 		$261 Buy
5
+1
+25% +$45 ﹤0.01% 1303
2025
Q1 		$171 Buy
+4
New +$173 ﹤0.01% 1470
2024
Q1 		– Sell
-5
Closed -$136 – 1665
2023
Q4 		$136 Buy
5
+1
+25% +$26 ﹤0.01% 1515
2023
Q3 		$119 Buy
+4
New +$141 ﹤0.01% 1522
2022
Q1 		$0 Buy
+1
New +$68 ﹤0.01% 942

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

SJS Investment Consulting's GH Position: Q2 2026 in Review

SJS Investment Consulting increased its Guardant Health (GH) stake by 8.9% in Q2 2026, buying an estimated $870 and bringing the position to 98 shares worth $14.7K. The position accounts for ﹤0.01% of the portfolio, ranked #912.

SJS Investment Consulting first reported a position in GH in Q1 2022 and has held it in 9 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • SJS Investment Consulting held 98 shares of Guardant Health worth $14.7K as of Q2 2026.
  • SJS Investment Consulting bought 8 Guardant Health shares in Q2 2026, an estimated $870.
  • Guardant Health made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #912 holding.
  • SJS Investment Consulting first reported a position in Guardant Health in Q1 2022 and has held it in 9 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.